Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells

S Durai, M Mani, K Kandavelou, J Wu… - Nucleic acids …, 2005 - academic.oup.com
S Durai, M Mani, K Kandavelou, J Wu, MH Porteus, S Chandrasegaran
Nucleic acids research, 2005academic.oup.com
Custom-designed zinc finger nucleases (ZFNs), proteins designed to cut at specific DNA
sequences, are becoming powerful tools in gene targeting—the process of replacing a gene
within a genome by homologous recombination (HR). ZFNs that combine the non-specific
cleavage domain (N) of FokI endonuclease with zinc finger proteins (ZFPs) offer a general
way to deliver a site-specific double-strand break (DSB) to the genome. The development of
ZFN-mediated gene targeting provides molecular biologists with the ability to site …
Abstract
Custom-designed zinc finger nucleases (ZFNs), proteins designed to cut at specific DNA sequences, are becoming powerful tools in gene targeting—the process of replacing a gene within a genome by homologous recombination (HR). ZFNs that combine the non-specific cleavage domain (N) of FokI endonuclease with zinc finger proteins (ZFPs) offer a general way to deliver a site-specific double-strand break (DSB) to the genome. The development of ZFN-mediated gene targeting provides molecular biologists with the ability to site-specifically and permanently modify plant and mammalian genomes including the human genome via homology-directed repair of a targeted genomic DSB. The creation of designer ZFNs that cleave DNA at a pre-determined site depends on the reliable creation of ZFPs that can specifically recognize the chosen target site within a genome. The (Cys 2 His 2 ) ZFPs offer the best framework for developing custom ZFN molecules with new sequence-specificities. Here, we explore the different approaches for generating the desired custom ZFNs with high sequence-specificity and affinity. We also discuss the potential of ZFN-mediated gene targeting for ‘directed mutagenesis’ and targeted ‘gene editing’ of the plant and mammalian genome as well as the potential of ZFN-based strategies as a form of gene therapy for human therapeutics in the future.
Oxford University Press